Sign in

CIK 0000879169 · Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943136539
Phone
3024986700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,959,897
in 5 filings, $33.0M under 10b5-1 plans

Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stein Steven H −$28.4M CMO & Head of Late-Stage Dev. sold 89% of stake
  2. CAGNONI PABLO J −$4.5M President, Global Head of R&D sold 17% of stake
  3. Tray Thomas −$73K Principal Accounting Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-04 Upadhyay Suketu EVP & Chief Financial Officer Grant or award · Performance Shares +13,171 26,342
2026-04-17 CAGNONI PABLO J President, Global Head of R&D Option exercise 10b5-1 +6,077 $64.25 $390K 268,769
2026-04-17 CAGNONI PABLO J President, Global Head of R&D Option exercise 10b5-1 +12,590 $71.93 $906K 281,359
2026-04-17 CAGNONI PABLO J President, Global Head of R&D Sale 10b5-1 −18,667 $96.50 $1.8M 262,692
2026-04-17 CAGNONI PABLO J President, Global Head of R&D Option exercise · Employee Stock Option (right to buy) 10b5-1 −6,077 26,833
2026-04-17 CAGNONI PABLO J President, Global Head of R&D Option exercise · Employee Stock Option (right to buy) 10b5-1 −12,590 27,699
2026-04-15 Stein Steven H CMO & Head of Late-Stage Dev. Grant or award +39,049 73,252
2026-04-15 Meury William Chief Executive Officer Option exercise +125,000 161,101
2026-04-15 CAGNONI PABLO J President, Global Head of R&D Grant or award +27,892 262,692
2026-03-31 Clancy Paul J Director Grant or award +265 $94.12 $25K 23,741
2026-03-31 BAKER BROS. ADVISORS LP Director Grant or award +421 2,818,039
2026-03-31 BAKER BROS. ADVISORS LP Director Grant or award +421 28,188,718
2026-03-31 HARRIGAN EDMUND Director Grant or award +269 $94.12 $25K 21,122
2026-03-25 Trotta Matteo EVP, GM, Dermatology US Shares withheld for taxes −537 $92.23 $50K 14,882
2026-03-17 CAGNONI PABLO J President, R&D Option exercise 10b5-1 +7,166 $61.18 $438K 241,966
2026-03-17 CAGNONI PABLO J President, R&D Option exercise 10b5-1 +11,501 $64.25 $739K 253,467
2026-03-17 CAGNONI PABLO J President, R&D Sale 10b5-1 −18,667 $94.24 $1.8M 234,800
2026-03-17 CAGNONI PABLO J President, R&D Option exercise · Employee Stock Option (right to buy) 10b5-1 −7,166 9,102
2026-03-17 CAGNONI PABLO J President, R&D Option exercise · Employee Stock Option (right to buy) 10b5-1 −11,501 32,910
2026-02-19 CAGNONI PABLO J President, R&D Option exercise 10b5-1 +13,093 $61.76 $809K 247,893

Page 11 of 15 · 293 trades